| Business Summary | | Bruker
Daltonics
Inc.
is
a
developer
and
provider
of
life
science
tools
using
mass
spectrometry.
The
Company
bases
its
life
science
solutions
on
four
core
mass
spectrometry
technology
platforms:
matrix-assisted
laser
desorption
ionization
time-of-flight
mass
spectrometry,
electrospray
ionization
time-of-flight
mass
spectrometry,
Fourier
transform
mass
spectrometry
and
ion
trap
mass
spectrometry.
The
Company's
life
science
customer
base
is
composed
primarily
of
end
users
and
includes
pharmaceutical,
biotechnology,
proteomics,
agricultural
biotechnology,
molecular
diagnostics
and
fine
chemical
companies,
as
well
as
commercial
laboratories,
university
laboratories,
medical
schools
and
other
not-for-profit
research
institutes
and
government
laboratories. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Bruker
Daltonics
Inc.
is
a
developer
and
provider
of
innovative
life
sciences
tools
based
on
mass
spectrometry,
offering
highly
accurate
molecular
information
on
a
given
sample
utilizing
automated
sample
preparation
robots.
For
the
six
months
ended
6/30/01,
net
revenue
rose
38%
to
$44.2
million.
Net
income
from
continuing
operations
totaled
$1.8
million,
up
from
$255
thousand.
Results
reflect
strong
demand
for
the
MALDI-TOF
and
Ion
Trap
Mass
Spectrometer
products
and
higher
interest
income. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Frank Laukien, Ph.D., 41 Chairman,
Pres, CEO | $239K | John Hulburt, 34 CFO | -- | Dieter Koch, Ph.D, 61 Director;
Managing Director of Bruker Daltonik GmbH | 155K | Jochen Franzen, Ph.D., 70 Managing
Director, Bruker Daltonik GmbH | 100K | Gary Kruppa, Ph.D., 39 VP
of the Fourier Transform Mass Spectrometry Division | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|